Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate in Huntington's Disease
NCT03515213Phase 2Completed
- Sponsor
- University of California, Irvine
- Start
- Apr 2017
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fenofibrate in Huntington's disease (HD), sponsored by University of California, Irvine. Started Apr 2017; status: completed.
02
Drugs
fenofibrate
03
Conditions
Huntington's disease (HD)
Beyond the preview
Go deeper on NCT03515213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03515213.